BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis
GlobalData, April 2012, Pages: 58
BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis
Summary
BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company utilizing purified recombinant human platelet-derived growth factor (rhPDGF-BB) in combination with tissue specific matrices as its primary technology platform for promotion of tissue healing and regeneration. It is involved in the development and commercialization of drug-device combination products that enhance the healing of orthopedic, periodontal, craniofacial and sports injuries. Further, the company’s range of products and product candidates combine recombinant protein therapeutics with tissue specific scaffolds that stimulate tissue healing and regeneration.
It also follows a strategy of making alliance with others in the healthcare industry for ensuring development, promotion and reach of its products in other geographies. As a part of the strategy, it has manufacturing supply agreements involving the two principal components, rhPDGF and ß-TCP, of GEM 21S from the manufacturers of FDA approved products. Also, the company maintains contractual obligations for supply agreements with Novartis, Kensey Nash and Cam Bioceramics B.V. The company is headquartered in Franklin, US.
This report is a source for data, analysis and actionable intelligence on the BioMimetic Therapeutics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
List of Tables
List of Figures
BioMimetic Therapeutics, Inc. - Business Description
Key Facts
BioMimetic Therapeutics, Inc. - Major Products and Services
BioMimetic Therapeutics, Inc. Pipeline Products by Equipment Type
BioMimetic Therapeutics, Inc. Pipeline Products by Development Stage
BioMimetic Therapeutics, Inc. Pipeline Products by Therapy Area
BioMimetic Therapeutics, Inc. Pipeline Products by Trial Phase
BioMimetic Therapeutics, Inc. Pipeline Products by Milestone Summary
Augment - Acute Tendon
Augment - Acute Tendon Product Status
Augment - Acute Tendon Product Description
Augment - Acute Tendon Product Patent Details
Augment - Chronic Tendon
Augment - Chronic Tendon Product Status
Augment - Chronic Tendon Product Description
Augment - Chronic Tendon Product Patent Details
Augment - Spine
Augment - Spine Product Status
Augment - Spine Product Description
Augment - Spine Product Patent Details
Augment Bone Graft
Augment Bone Graft Product Status
Augment Bone Graft Product Description
Augment Bone Graft Product Milestone
Augment Bone Graft Product Patent Details
Augment Cartilage Repair
Augment Cartilage Repair Product Status
Augment Cartilage Repair Product Description
Augment Cartilage Repair Product Patent Details
Augment Injectable Bone Graft
Augment Injectable Bone Graft Product Status
Augment Injectable Bone Graft Product Description
Augment Injectable Bone Graft Product Milestone
Augment Injectable Bone Graft Product Patent Details
Augment Rotator Cuff Graft
Augment Rotator Cuff Graft Product Status
Augment Rotator Cuff Graft Product Description
Augment Rotator Cuff Graft Product Patent Details
Augment Tendon/Ligament Repair
Augment Tendon/Ligament Repair Product Status
Augment Tendon/Ligament Repair Product Description
Augment Tendon/Ligament Repair Product Patent Details
BioMimetic Therapeutics, Inc. - Key Competitors
BioMimetic Therapeutics, Inc. - Key Employees
BioMimetic Therapeutics, Inc. - Key Employee Biographies
BioMimetic Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
BioMimetic Therapeutics, Inc., Recent Developments
Mar 13, 2012: BioMimetic Reports Revenue Of $1.7m In 2011
Feb 08, 2012: BioMimetic To Introduce Augmatrix Biocomposite Bone Graft Product Line At AAOS
Nov 08, 2011: BioMimetic Reports Q3 2011 Results
Aug 04, 2011: BioMimetic Reports Q2 2011 Results
Jul 08, 2011: Izard Nobel Announces Class Action Lawsuit Against BioMimetic Therapeutics
Jul 07, 2011: Harwood Feffer Announces Class Action Lawsuit Against Biomimetic
May 09, 2011: BioMimetic Reports Q1 2011 Results
Mar 10, 2011: BioMimetic Reports Total Revenues Of $1.5m In 2010
Feb 17, 2011: BioMimetic Therapeutics Highlights Commercial And Product Development Activities During AAOS
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
BioMimetic Therapeutics, Inc., Key Facts
BioMimetic Therapeutics, Inc. Key Pipeline Products by Equipment Type
BioMimetic Therapeutics, Inc. Key Pipeline Products by Therapy Area
BioMimetic Therapeutics, Inc. Key Pipeline Products by Development Stage
BioMimetic Therapeutics, Inc. Key Pipeline Products by Trial Phase
BioMimetic Therapeutics, Inc., Key Facts
BioMimetic Therapeutics, Inc., Major Products and Services
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Equipment Type
BioMimetic Therapeutics, Inc. Pipeline Products by Equipment Type
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Development Stage
BioMimetic Therapeutics, Inc. Pipeline Products by Development Stage
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Therapy Area
BioMimetic Therapeutics, Inc. Pipeline Products by Therapy Area
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Trial Phase
BioMimetic Therapeutics, Inc. Pipeline Products by Trial Phase
BioMimetic Therapeutics, Inc. Number of Pipeline Products By Milestone Summary
BioMimetic Therapeutics, Inc. Pipeline Products by Milestone Summary
Augment - Acute Tendon - Product Status
Augment - Acute Tendon - Product Description
Augment - Acute Tendon - Patent Details
Augment - Chronic Tendon - Product Status
Augment - Chronic Tendon - Product Description
Augment - Chronic Tendon - Patent Details
Augment - Spine - Product Status
Augment - Spine - Product Description
Augment - Spine - Patent Details
Augment Bone Graft - Product Status
Augment Bone Graft - Product Description
Augment Bone Graft - Product Milestone
Augment Bone Graft - Patent Details
Augment Cartilage Repair - Product Status
Augment Cartilage Repair - Product Description
Augment Cartilage Repair - Patent Details
Augment Injectable Bone Graft - Product Status
Augment Injectable Bone Graft - Product Description
Augment Injectable Bone Graft - Product Milestone
Augment Injectable Bone Graft - Patent Details
Augment Rotator Cuff Graft - Product Status
Augment Rotator Cuff Graft - Product Description
Augment Rotator Cuff Graft - Patent Details
Augment Tendon/Ligament Repair - Product Status
Augment Tendon/Ligament Repair - Product Description
Augment Tendon/Ligament Repair - Patent Details
BioMimetic Therapeutics, Inc., Key Employees
BioMimetic Therapeutics, Inc., Key Employee Biographies
BioMimetic Therapeutics, Inc., Subsidiaries
List of Figures
BioMimetic Therapeutics, Inc. Key Pipeline Products by Equipment Type
BioMimetic Therapeutics, Inc. Pipeline Products by Equipment Type
BioMimetic Therapeutics, Inc. Pipeline Products by Development Stage
BioMimetic Therapeutics, Inc. Pipeline Products by Therapy Area
BioMimetic Therapeutics, Inc. Pipeline Products by Trial Phase
BioMimetic Therapeutics, Inc. Pipeline Products by Milestone Summary
Smith & Nephew Plc
Arteriocyte Medical Systems, Inc.
OLYMPUS CORPORATION
Synthes, Inc.
LifeCell Corporation
Stryker Corporation
DePuy Orthopaedics, Inc.
Zimmer Holdings, Inc.
Musculoskeletal Transplant Foundation
Medtronic, Inc.
CryoLife, Inc.
Wright Medical Group, Inc.
Biomet, Inc.
Regeneration Technologies, Inc.
Exactech, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network